Browsing Category
Health
We’re drawing on our massive money holdings to purchase extra of this healthcare inventory
We buy 90 shares of Cardinal Health for about $217. After the trade, Jim Cramer's Charitable Trust will own 350 shares of Cardinal, increasing its stake from 1.46% to about 2%. We may have opened a new position in Cardinal Health too early…
The FDA approves leucovorin for the remedy of cerebral folate deficiency, however not for autism
The Food and Drug Administration on Tuesday approved a decades-old prescription vitamin called leucovorin as the first treatment for a rare genetic disorder in certain adults and children. The move comes months after the Trump…
The Vertex kidney drug povetacicept is profitable within the research for IgAN
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston.Brian Snyder | ReutersVertex Pharmaceuticals said its experimental drug for a rare kidney disease successfully passed a Phase 3 trial, a key step in the…
Novo Nordisk ends authorized proceedings in opposition to Hims & Hers
Novo Nordisk has dropped its legal proceedings against the telemedicine provider Him and him for patent infringement after the two companies agreed that Hims would sell Novo's branded drugs through its platform. "We have decided to…
FDA retractions on UniQure and Moderna approvals fear traders
Investors are worried about the fate of several experimental drugs for hard-to-treat diseases after a series of recent rejections by the U.S. Food and Drug Administration (FDA). According to RTW Investments, the FDA has rejected or advised…
Within the booming enterprise of wellness golf equipment and third areas
A few years ago, Grace Guo began to long for places in New York City where hanging out with friends didn't necessarily have to involve alcohol.Guo was newly sober and surrounded by friends who also didn't want to drink. She said she wanted…
FDA’s vaccine chief will resign in April after a collection of controversial selections
The Food and Drug Administration logo is seen before a press conference at the Health and Human Services headquarters on April 22, 2025 in Washington, DC.Nathan Posner | Anadolu | Getty ImagesA key U.S. Food and Drug Administration official…
FDA official discusses UniQure gene remedy for Huntington’s illness
Thomas Fuller | SOPA images | Light rocket | Getty ImagesUniQure needs to conduct another study to prove that its gene therapy "actually helps people with Huntington's disease," a senior U.S. Food and Drug Administration official said in…
We have been energetic in buying and selling throughout the aftermath of the Iran Battle. Jim Cramer…
Jim Cramer explained Tuesday morning why the Investing Club is trying to strike a delicate balance with its actions during the Iran War's impact on the stock market. "Those who flee in moments like these can never get back in," Jim stressed…
Here is Jim Cramer’s recommendation for navigating the markets throughout the Iran battle
Jim Cramer's advice for investors dealing with the fallout from the US-Israeli attack on Iran: Be selective. With stocks initially selling off (but well off their lows in late morning trading; stay tuned) and oil prices surging on fears of…